ONCO vs WY · P/E 0.0, rev $815.4K vs P/E 43, rev $3.59B
Onconetix Inc (ONCO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
ONCO currently screens at market cap $3.7M and trailing P/E 0.0. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the ONCO and WY stock pages for the full models.
Not investment advice.